Recombinant Glargine Insulin Production Process Using Escherichia coli |
Hwang, Hae-Gwang
(Department of Pharmacy, Sunchon National University)
Kim, Kwang-Jin (Department of Pharmacy, Sunchon National University) Lee, Se-Hoon (Department of Pharmacy, Sunchon National University) Kim, Chang-Kyu (Division of Animal Resources and Life Science, Sangji University) Min, Cheol-Ki (Department of Integrated Biotechnology, Sogang University) Yun, Jung-Mi (Department of Food and Nutrition, Chonnam National University) Lee, Su Ui (Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology) Son, Young-Jin (Department of Pharmacy, Sunchon National University) |
1 |
Rasmussen LJ, Lobner-Olesen A, Marinus MG. 1995. Growth-rate-dependent transcription initiation from the |
2 |
Rudolph R, Lilie H. 1996. In vitro folding of inclusion body proteins. |
3 |
Schnaitman CA. 1971. Effect of ethylenediaminetetraacetic acid, Triton X-100, and lysozyme on the morphology and chemical composition of isolate cell walls of |
4 |
Seo MJ, Choi HJ, Chung KH, Pyun YR. 2011. Production of a platelet aggregation inhibitor, salmosin, by high cell density fermentation of recombinant |
5 |
Shetty JK, Kinsella JE. 1980. Ready separation of proteins from nucleoprotein complexes by reversible modification of lysine residues. |
6 |
Shiloach J, Fass R. 2005. Growing |
7 |
Bottazzo GF, Florin-Christensen A, Doniach D. 1974. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. |
8 |
Clark EDB. 1998. Refolding of recombinant proteins. |
9 |
Evnin LB, Vasquez JR, Craik CS. 1990. Substrate specificity of trypsin investigated by using a genetic selection. |
10 |
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 2003. Report of the expert committee on the diagnosis and classification of diabetes mellitus. |
11 |
Sreenivas S, Krishnaiah SM, Govindappa N, Basavaraju Y, Kanojia K, Mallikarjun N, |
12 |
Sonksen P, Sonksen J. 2000. Insulin: understanding its action in health and disease. |
13 |
Ferrannini E. 2012. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. |
14 |
Galloway JA, Chance RE. 1994. Improving insulin therapy: achievements and challenges. |
15 |
Gavin III JR, Alberti K, Davidson MB, DeFronzo RA. 1997. Report of the expert committee on the diagnosis and classification of diabetes mellitus. |
16 |
Graf L, Jancso A, Szilagyi L, Hegyi G, Pinter K, Naray-Szabo G, |
17 |
Son Y, Kim C, Kim YB, Kweon D, Park Y, Seo J. 2009. Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B. |
18 |
Son Y, Park K, Lee S, Oh S, Kim C, Choi B, Park Y, Seo J. 2007. Effects of temperature shift strategies on human preproinsulin production in the fed-batch fermentation of recombinant |
19 |
Yadav S, Parakh A. 2006. Insulin therapy. |
20 |
Gu Z, Weidenhaupt M, Ivanova N, Pavlov M, Xu B, Su Z, Janson J. 2002. Chromatographic methods for the isolation of, and refolding of proteins from, |
21 |
Habeeb A, Atassi MZ. 1970. Enzymic and immunochemical properties of lysozyme. Evaluation of several amino group reversible blocking reagents. |
22 |
Haist RE, Best CH. 1940. Factors affecting the insulin content of pancreas. |
23 |
Kadlčík V, Strohalm M, Kodíček M. 2003. Citraconylation — a simple method for high protein sequence coverage in MALDI-TOF mass spectrometry. |
24 |
Lan MS, Wasserfall C, Maclaren NK, Notkins AL. 1996. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. |
25 |
Khajeh K, Naderi-Manesh H, Ranjbar B, Moosavi-Movahedi A, Nemat-Gorgani M. 2001. Chemical modification of lysine residues in |
26 |
Korz DJ, Rinas U, Hellmuth K, Sanders EA, Deckwer WD. 1995. Simple fed-batch technique for high cell density cultivation of |
27 |
Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. |
28 |
Middelberg AP, O’Neill BK. 1991. Monitoring the centrifugal recovery of recombinant protein inclusion bodies. |
29 |
Lee SY. 1996. High cell-density culture of |
30 |
Loghmani E. 2005. Diabetes mellitis: type 1 and type 2, pp. 167-182. In Stang J, Story M (eds.). |
31 |
Olsen JV, Ong SE, Mann M. 2004. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. |
32 |
Alberti KG, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. |
33 |
Mossavarali S, Hosseinkhani S, Ranjbar B, Miroliaei M. 2006. Stepwise modification of lysine residues of glucose oxidase with citraconic anhydride. |
34 |
Murray HD, Appleman JA, Gourse RL. 2003. Regulation of the |
35 |
Naglak TJ, Wang HY. 1990. Recovery of a foreign protein from the periplasm of |
36 |
Nieto MA, Palacián E. 1983. Effects of temperature and pH on the regeneration of the amino groups of ovalbumin after modification with citraconic and dimethylmaleic anhydrides. |
37 |
Owens DR, Zinman B, Bolli GB. 2001. Insulins today and beyond. |
38 |
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, |
39 |
Baeshen NA, Baeshen MN, Sheikh A, Bora RS, Ahmed MM, Ramadan HA, |
40 |
Owens DR. 2002. New horizons — alternative routes for insulin therapy. |
41 |
Poon K, King AB. 2010. Glargine and detemir: safety and efficacy profiles of the long-acting basal insulin analogs. |
42 |
Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, |
43 |
Bhambure R, Rathore AS. 2013. Chromatography process development in the quality by design paradigm I: establishing a high-throughput process development platform as a tool for estimating “characterization space” for an ion exchange chromatography step. |
44 |
Bindels J, Misdom L, Hoenders H. 1985. The reaction of citraconic anhydride with bovine α-crystallin lysine residues. Surface probing and dissociation-reassociation studies. |
45 |
Bolli G, Di Marchi R, Park G, Pramming S, Koivisto VA. 1999. Insulin analogues and their potential in the management of diabetes mellitus. |
46 |
Borg N, Brodsky Y, Moscariello J, Vunnum S, Vedantham G, Westerberg K, Nilsson B. 2014. Modeling and robust pooling design of a preparative cation-exchange chromatography step for purification of monoclonal antibody monomer from aggregates. |